Table 2. Intra-lesional steroid regimes used in studies included in the systematic review.

Study	ILS type	ILS single dose (mg)	Dosage range	Total dosage range (mg)	Frequency of dosage	Topical steroid use
Alper et al. (22) 2020	Methylprednisolone acetate	40	2–7	80–280	3–4 weekly	No
Toktas and Toprak (27) 2021	Methylprednisolone acetate	40	1–2	40–80	2-weekly	0.125% prednisolone twice a day, EOD for 1 month
Ertürk et al. (23) 2022	Triamcinolone acetonide	40–80	1–5	40–400	4-weekly	Triamcinolone Daily - 1 month (after ILS)
Kim et al. (24) 2016	Triamcinolone acetonide	40	2–6	80–240	1–2 weekly	No
Tang et al. (25) 2020	Triamcinolone acetonide	80–160	1	80–160	Single dose	No
Toktas et al. (26) 2021	Triamcinolone acetonide	20 mg	1–3	20 mg up to 3 times	4-weekly	Triamcinolone acetonide 0.1%, twice a day, EOD for 1 month
Yildirim et al. (28) 2021	Triamcinolone acetonide	40	1–5	40–200	1 weekly	No
Karami et al. (21) 2022	Betamethasone disodium phosphate + betamethasone acetate	6	1–4	6–24	1 weekly	No

ILS: Intralesional steroid